 BALA CYNWYD, Pa., June 11, 2021 GLOBE NEWSWIRE -- Larimar Therapeutics, Inc. Larimar Nasdaq: LRMR, a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar Therapeutics, will present and participate in virtual 1x1 investor meetings at the JMP Securities Life Sciences Conference taking place from June 16-17, 2021. See below for more details. 